TCH Pharmaceuticals scores $200K in loans, retains ex-Pfizer talent

Ann Arbor-based TCH Pharmaceuticals will use a $200,000 loan from the state of Michigan to hire four people, all ex-Pfizer employees.”These four will be the first employees of the company,” says Thomas A Collet, president and CEO of TCH Pharmaceuticals.The 4-year-old company, currently staffed by its three co-founders, commercializes non-toxic proteasome inhibitors to be used in therapies that treat inflammatory diseases. It is using technology licensed from Michigan State University. “We have a family of compounds we want to take into clinical development,” Collet says. “They would help us do that.”TCH Pharmaceuticals (TCH is an acronym for the founders’ last names) is one of five Michigan companies to share the most recent $530,000 in loans from the state’s Company Formation and Growth Fund. That initiative began in 2007, shortly after Pfizer announced the closing of its Ann Arbor campus. It’s aimed at keeping Pfizer’s talent in-state by accelerating start-up formation and growth. The fund has made $8 million in loans to a total of 41 life-science companies in Ann Arbor, Chelsea, Jackson, Livonia, and Saline.Source: Thomas A Collet, president and CEO of TCH PharmaceuticalsWriter: Jon Zemke

Getting your Trinity Audio player ready...

Ann Arbor-based TCH Pharmaceuticals will use a $200,000 loan from the state of Michigan to hire four people, all ex-Pfizer employees.

“These four will be the first employees of the company,” says Thomas A Collet, president and CEO of TCH Pharmaceuticals.

The 4-year-old company, currently staffed by its three co-founders, commercializes non-toxic proteasome inhibitors to be used in therapies that treat inflammatory diseases. It is using technology licensed from Michigan State University.

“We have a family of compounds we want to take into clinical development,” Collet says. “They would help us do that.”

TCH Pharmaceuticals (TCH is an acronym for the founders’ last names) is one of five Michigan companies to share the most recent $530,000 in loans from the state’s Company Formation and Growth Fund. That initiative began in 2007, shortly after Pfizer announced the closing of its Ann Arbor campus. It’s aimed at keeping Pfizer’s talent in-state by accelerating start-up formation and growth. The fund has made $8 million in loans to a total of 41 life-science companies in Ann Arbor, Chelsea, Jackson, Livonia, and Saline.

Source: Thomas A Collet, president and CEO of TCH Pharmaceuticals
Writer: Jon Zemke

Author

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU

Common Ground Is Brewing

Support local stories and receive our signature roast straight to your door when you join at the Standard level (or above).

Drink Better, Read Local

Close the CTA

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.